Brief: LifeTech Scientific Announces LAmbreTM LAA Closure System Obtained Approval By US FDA For Clinical Trial
30/12/2020 06:15
Dec 30 (Reuters) - LifeTech Scientific Corp 1302.HK :
* ANNOUNCES LAMBRETM LAA CLOSURE SYSTEM OBTAINED APPROVAL BY
US
FDA FOR CLINICAL TRIAL
Source text for Eikon: ID:nHKS8K3yjg
Further company coverage: 1302.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LifeTech Scientific
See all newsBrief: Lifetech Scientific's Ics Elpis Admitted To Nmpa Special Examination On October 19, 2026
Brief: Lifetech Scientific Says Surechamtm Stent Graft Admitted To Nmpa Special Examination And Approval Procedure
Brief: Lifetech Scientific Expects Net Profit Attributable For Six Months Ended June 2026
Brief: Lifetech Scientific To Not Proceed With Major Deal
Brief: Lifetech Scientific To Buy 96.46% Of Starway Medical Technology